Aminosalicylate Therapy in the Prevention of Dysplasia and Colorectal Cancer in Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 11, 2006, Pages 1346-1350

  Rubin, David T ^a   LoSavio, Andelka ^a   Yadron, Nicole ^a   Huo, Dezheng ^a   Hanauer, Stephen B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; MESALAZINE; OLSALAZINE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; DRUG FORMULATION; DYSPLASIA; FAMILY HISTORY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; RISK; RISK REDUCTION; ULCERATIVE COLITIS;

ADULT; AMINOSALICYLIC ACIDS; CASE-CONTROL STUDIES; CHEMOPREVENTION; CHRONIC DISEASE; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; SULFASALAZINE;

EID: 33750797496     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.08.014     Document Type: Article

References (21)

1. Gyde S.N., Prior P., Allan R.N., et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut 29 (1988) 206-217
2. Lennard-Jones J.E. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 72 Suppl (1985) S84-S86
3. Collins R.H., Feldman M., and Fordtran J.S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316 (1987) 1654-1658
4. Greenstein A.J., Sachar D.B., Smith H., et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 77 (1979) 290-294
5. Sugita A., Sachar D.B., Bodian C., et al. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32 (1991) 167-169
6. Levin B. Inflammatory bowel disease and colon cancer. Cancer 70 (1992) 1313-1316
7. Brentnall T.A., Haggitt R.C., Rabinovitch P.S., et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110 (1996) 331-338
8. Nuako K.W., Ahlquist D.A., Mahoney D.W., et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 115 (1998) 1079-1083
9. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004) 451-445
10. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323 (1990) 1228-1233
11. Katzka I., Brody R.S., Morris E., et al. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 85 (1983) 22-29
12. Mir-Madjlessi S.H., Farrer R.G., Easley K.A., et al. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 58 (1986) 1569-1574
13. Kornbluth A., Sachar D.B., American College of Gastroenterology, and Practice Parameters Committee. Ulcerative colitis practice guidelines in adults. (update). Am J Gastroenterol 99 (2004) 1371-1385
14. Itzkowitz S.H., and Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11 (2005) 314-321
15. Giovannucci E., Egan K.M., Hunter D.J., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 333 (1995) 609-614
16. Pinczowski D., Ekbom A., Baron J., et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107 (1994) 117-120
17. Bernstein C.N., Blanchard J.F., Metge C., et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?. Am J Gastroenterol 98 (2003) 2784-2788
18. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14 (2000) 145-153
19. van Staa T.P., Card T.R., Leufkens H.G., et al. 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54 (2005) 1573-1578
20. Velayos F.S., Terdiman J.P., and Walsh J.M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 100 (2005) 1345-1353
21. Rubin D.T., and Lashner B.A. Will a 5-ASA a day keep the cancer (and dysplasia) away?. Am J Gastroenterol 100 (2005) 1354-1356